DK1879656T3 - Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol - Google Patents

Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol

Info

Publication number
DK1879656T3
DK1879656T3 DK06744739.1T DK06744739T DK1879656T3 DK 1879656 T3 DK1879656 T3 DK 1879656T3 DK 06744739 T DK06744739 T DK 06744739T DK 1879656 T3 DK1879656 T3 DK 1879656T3
Authority
DK
Denmark
Prior art keywords
carveol
carvacrol
thymol
pharmaceutical composition
active substance
Prior art date
Application number
DK06744739.1T
Other languages
English (en)
Inventor
Adnane Remmal
Original Assignee
Advanced Scient Developements
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scient Developements filed Critical Advanced Scient Developements
Application granted granted Critical
Publication of DK1879656T3 publication Critical patent/DK1879656T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06744739.1T 2005-05-13 2006-05-15 Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol DK1879656T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2005/001314 WO2006120495A1 (fr) 2005-05-13 2005-05-13 Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
PCT/IB2006/001328 WO2006120564A1 (fr) 2005-05-13 2006-05-15 Composition pharmaceutique comprenant un antiviral , un antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol , le thymol, l' eugenol, le borneol et le carvacrol

Publications (1)

Publication Number Publication Date
DK1879656T3 true DK1879656T3 (da) 2012-07-23

Family

ID=35427309

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06755932.8T DK1883452T3 (da) 2005-05-13 2006-05-15 Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol
DK06744739.1T DK1879656T3 (da) 2005-05-13 2006-05-15 Farmaceutisk sammensætning omfattende et antitumoralt middel og en aktiv substans udvalgt fra især carveol, thymol og carvacrol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06755932.8T DK1883452T3 (da) 2005-05-13 2006-05-15 Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol

Country Status (16)

Country Link
US (2) US20080171709A1 (da)
EP (2) EP1879656B1 (da)
JP (1) JP5073651B2 (da)
CN (2) CN101175532B (da)
AP (1) AP2437A (da)
AT (1) ATE554827T1 (da)
BR (2) BRPI0610123A2 (da)
CA (2) CA2606887C (da)
DK (2) DK1883452T3 (da)
EA (1) EA015168B1 (da)
ES (2) ES2399348T3 (da)
MA (2) MA29573B1 (da)
PT (2) PT1879656E (da)
TN (2) TNSN07423A1 (da)
WO (3) WO2006120495A1 (da)
ZA (1) ZA200710785B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008029136A1 (en) * 2006-09-05 2008-03-13 Ultra Biotech Limited Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
WO2010107791A2 (en) 2009-03-17 2010-09-23 Concert Pharmaceuticals, Inc. Pyrazinoisoquinoline compounds
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
BR112013013085B1 (pt) 2010-12-07 2018-02-14 Unilever N.V. Composição de cuidados orais, enxaguante bucal, creme dental, dentífrico, método para desinfetar a cavidade oral e uso de uma composição
EA024551B1 (ru) 2011-11-03 2016-09-30 Юнилевер Н.В. Индивидуальная композиция для очищения
CN102579449B (zh) * 2012-03-30 2013-08-07 厦门大学 一种可提高肿瘤对紫杉醇敏感性的联合用药
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
KR20170129896A (ko) * 2015-03-20 2017-11-27 새미 오유 오피요 악성 신생물에 대한 수라민 및 아르기나아제 억제제의 용도
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
CN105147647A (zh) * 2015-08-19 2015-12-16 华南理工大学 右旋龙脑作为抗肿瘤药物增敏剂的应用
WO2017209588A2 (fr) 2016-06-02 2017-12-07 Advanced Scientific Developements Formulation pharmaceutique de cinéol et d'amoxicilline
MX2019011678A (es) * 2017-03-28 2020-02-12 IRP Health Pty Ltd Alcaloides de berberina en la prevencion y/o tratamiento de una enfermedad intestinal.
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
CN112972437B (zh) * 2021-02-19 2022-03-25 沈阳伟嘉生物技术有限公司 一种包含碘硝酚的长效外用制剂及其制备方法和用途
CN121550195A (zh) * 2026-01-21 2026-02-24 哈尔滨医科大学 β-紫罗兰酮在制备肿瘤免疫调节剂中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE19509697A1 (de) * 1995-03-08 1996-09-12 Schering Ag Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
EP1137426B1 (en) * 1998-12-07 2005-10-26 Ecosmart Technologies, Inc. Breast cancer treatment using natural plant essential oils
US6536268B1 (en) * 1999-11-01 2003-03-25 Siemens Vdo Automotive Corporation Utilizing increasing width for identification voltages
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2004513153A (ja) * 2000-11-09 2004-04-30 イェルク・ペーター・シューア Ｇｒａｓ香料またはその誘導体を含む殺菌性組成物を含有する薬物
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
WO2002062316A1 (de) * 2001-02-08 2002-08-15 Vectron Therapeutics Ag Invasomen zur therapie von erkrankungen, ihre herstellung und verwendung
AU2003211149A1 (en) * 2002-02-20 2003-09-09 Pharmessen Scientific, Inc. Antimicrobial therapeutic compositions and methods of use
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
BR0316776A (pt) * 2002-12-10 2005-10-25 Biosynexus Inc Formula para anti-infeccioso tópico
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CN100343223C (zh) * 2005-03-07 2007-10-17 常州市智能动物药业有限公司 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物

Also Published As

Publication number Publication date
CN101193682B (zh) 2012-06-13
CA2608061A1 (fr) 2006-11-16
JP2008540505A (ja) 2008-11-20
EP1883452B1 (fr) 2012-12-19
EP1879656A1 (fr) 2008-01-23
PT1883452E (pt) 2013-02-18
US20080171709A1 (en) 2008-07-17
CN101193682A (zh) 2008-06-04
JP5073651B2 (ja) 2012-11-14
AP2437A (en) 2012-08-31
CN101175532B (zh) 2011-12-28
WO2006120568A2 (fr) 2006-11-16
EP1879656B1 (fr) 2012-04-25
DK1883452T3 (da) 2013-02-25
PT1879656E (pt) 2012-07-25
TNSN07423A1 (fr) 2009-03-17
AP2007004228A0 (en) 2007-12-31
EA015168B1 (ru) 2011-06-30
MA29908B1 (fr) 2008-11-03
CA2608061C (fr) 2014-07-15
ZA200710785B (en) 2009-06-24
CN101175532A (zh) 2008-05-07
ES2399348T3 (es) 2013-03-27
EA200702486A1 (ru) 2008-06-30
WO2006120568A3 (fr) 2007-08-23
WO2006120564A1 (fr) 2006-11-16
ATE554827T1 (de) 2012-05-15
ES2386292T3 (es) 2012-08-16
BRPI0610123A2 (pt) 2012-09-25
CA2606887A1 (fr) 2006-11-16
MA29573B1 (fr) 2008-06-02
CA2606887C (fr) 2014-07-15
TNSN07426A1 (fr) 2009-03-17
EP1883452A2 (fr) 2008-02-06
BRPI0610130A2 (pt) 2012-09-25
WO2006120495A1 (fr) 2006-11-16
US20080171768A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
HUE043555T2 (hu) Tetrahidrokannabinol gyógyszer elõanyagai (prodrugjai), kompozíciók, amelyek tetrahidrokannabinol gyógyszer elõanyagait tartalmazzák, és eljárások, ezek alkalmazására
DK1883452T3 (da) Farmaceutisk sammensætning indeholdende et anti-parasitmiddel og et aktivstof valgt fra thymol, eugenol eller carvacrol
IL208370A0 (en) Improved formulations for poorly permeable active pharmaceutical ingredients
IL188150A0 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
NO20070046L (no) Nytt cykloheksanderivat, prodrug derav og salt derav, og terapeutisk middel inneholdende de samme for diabetes
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0810552A2 (pt) Composição de substância ativa, processos para preparar uma composição de substância ativa, e para preparar sementes contenda substância ativa, uso da composição de substância ativa, sementes, e, composição aquosa.
IL196113A0 (en) N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
BRPI0917006A2 (pt) agente de liberação prolongada de droga, adsorvente, alimento, máscara tendo um adsorvente, e, folha de adsorção
IL196571A0 (en) N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
DK1890588T3 (da) Ambulant lægemiddelindretning og fremgangsmåde til kommunikation mellem lægemiddelindretninger
HUE043897T2 (hu) Lipofil hatóanyagot tartalmazó készítmények és eljárás elõállításukra
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
IL196108A0 (en) Active agent formulations, methods of making, and methods of use
DK1690550T3 (da) Terapeutisk middel til mesothelioma
NO20075628L (no) Farmasøytiske formuleringer
BRPI0814891A2 (pt) Composição farmacêutica contendo composto oticamente ativo tendo atividade agonista de receptor de trombopoietina, e intermediário do mesmo.
CL2007001917A1 (es) Compuestos derivados de azaindol espirociclicos; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del dolor, condiciones de panico, depresion, mal de alzheimer, migrana, entre otras.
BRPI0915552A2 (pt) derivados de ciclosporina, seu uso e sua composição farmacêutica
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
ATE490967T1 (de) 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
DK1879654T3 (da) Farmaceutisk kombination af et afsvampningsmiddel og en aktiv substans, som navnlig er eugenol og carvacrol
DK2024329T3 (da) (2r)-2-[(4-sulfonyl)aminophenyl]propanamider og farmaceutiske sammensætninger indeholdende dem